Valsts: Armēnija
Valoda: angļu
Klimata pārmaiņas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
clobetasol (clobetasol propionate)
Delpharm Poznan Spolka Akcyjna
D07AD01
clobetasol (clobetasol propionate)
0,5mg/g
cream
aluminium tube 25g
Prescription
Registered
2023-06-21
PACKAGE LEAFLET: INFORMATION FOR THE USER DERMOVATE CREAM DERMOVATE OINTMENT _Clobetasol propionate _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1 What Dermovate is and what it is used for 2 What you need to know before you use Dermovate 3 How to use Dermovate 4 Possible side effects 5 How to store Dermovate 6 Contents of the pack and other information 1. WHAT DERMOVATE IS AND WHAT IT IS USED FOR Dermovate contains a medicine called clobetasol propionate. It belongs to a group of medicines called steroids. It helps to reduce swelling and irritation. Dermovate is used to help reduce the redness and itchiness of certain skin problems. These skin problems include: • frequently relapsing eczema • psoriasis (thickened patches of inflamed, red skin, often covered by silvery scales), excluding widespread plaque psoriasis • lichen planus (a skin disease that causes itchy, reddish-purple, flat-topped bumps on the wrists, forearms or lower legs) • discoid lupus erythematosus (a disease of the skin most often affecting the face, ears and scalp causing scarring and increased sensitivity of the affected skin to sunlight) • dermatitis and other skin conditions that have not responded to milder steroid creams or ointments. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE DERMOVATE Do not use Dermovate: • if you are allergic (hypersensitive) to clobetasol propionate or any of the other ingredients of this medicine (listed in Section 6) • on a child under 1 year of age • to treat any of the following skin pr Izlasiet visu dokumentu
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Dermovate Cream Dermovate Ointment 2. QUALITATIVE AND QUANTITATIVE COMPOSITION CREAM: Clobetasol propionate 0.0525% w/w Excipients with known effect: Cetosteryl alcohol Clorocresol Propylene glycol OINTMENT: Clobetasol 17-propionate 0.05375% w/w Excipients with known effect: Propylene Glycol For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Cream Ointment 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clobetasol is a very potent topical corticosteroid indicated for adults, elderly and children over 1 year for the short term treatment only of more resistant inflammatory and pruritic manifestations of steroid responsive dermatoses unresponsive to less potent corticosteroids. These include the following: • Psoriasis (excluding widespread plaque psoriasis) • Recalcitrant dermatoses • Lichen planus • Discoid lupus erythematosus • Other skin conditions which do not respond satisfactorily to less potent steroids. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION CLOBETASOL PROPIONATE BELONGS TO THE MOST POTENT CLASS OF TOPICAL CORTICOSTEROIDS (GROUP IV) AND PROLONGED USE MAY RESULT IN SERIOUS UNDESIRABLE EFFECTS (SEE SECTION 4.4). IF TREATMENT WITH A LOCAL CORTICOSTEROID IS CLINICALLY JUSTIFIED BEYOND 4 WEEKS, A LESS POTENT CORTICOSTEROID PREPARATION SHOULD BE CONSIDERED. REPEATED BUT SHORT COURSES OF CLOBETASOL PROPIONATE MAY BE USED TO CONTROL EXACERBATIONS (SEE DETAILS BELOW). ROUTE OF ADMINISTRATION: Cutaneous Ointments are especially appropriate for dry, lichenified or scaly lesions. Creams are especially appropriate for moist or weeping surfaces. ADULTS, ELDERLY AND CHILDREN OVER 1 YEAR Apply thinly and gently rub in using only enough to cover the entire affected area once or twice a day until improvement occurs (in the more responsive conditions this may be within a few days), then reduce the frequency of application or change the treatment to a less potent preparation. Allow adequate time for absorption after each ap Izlasiet visu dokumentu